The validation dataset ICGC-LIHC-JP confirmed that the genes TRMT6, TRMT61A, TRMT10C, and YTHDF1 had good risk prediction value for HCC survival, and elevated TRMT6 gene expression was associated with poor prognosis. This evidence concerns the gene TRMT61A and hepatocellular carcinoma.